Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl-Pyridazine Moiety for the Potential Treatment of Alzheimer's Disease
<b>Background</b>: Alzheimer's disease (AD) is characterized by cholinergic dysfunction, making the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) critical for improving cholinergic neurotransmission. However, the development of effective dual inhibitors...
Saved in:
Main Authors: | Mohamed Elsawalhy (Author), Adel A-H (Author), Ebtesam A. Basiony (Author), Salma A. Ellithy (Author), Allam A. Hassan (Author), Eman S. Abou-Amra (Author), Abdelhamid Ismail (Author), Abdulrahman A. Almehizia (Author), Mohamed A. Al-Omar (Author), Ahmed M. Naglah (Author), Nasser A. Hassan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel Inhibitors of Acetyl- and Butyrylcholinesterase Derived from Benzohydrazides: Synthesis, Evaluation and Docking Study
by: Neto-Honorius Houngbedji, et al.
Published: (2023) -
Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent
by: Shuang Miao, et al.
Published: (2022) -
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates
by: Hyun Myung Lee, et al.
Published: (2021) -
Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities
by: Maiy Y. Jaballah, et al.
Published: (2019) -
5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study
by: Václav Pflégr, et al.
Published: (2022)